These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18212541)

  • 1. Retiform hemangioendotheliomas usually do not express D2-40 and VEGFR-3.
    Parsons A; Sheehan DJ; Sangueza OP
    Am J Dermatopathol; 2008 Feb; 30(1):31-3. PubMed ID: 18212541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
    Folpe AL; Veikkola T; Valtola R; Weiss SW
    Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retiform hemangioendothelioma: presentation of a case expressing D2-40.
    Emberger M; Laimer M; Steiner H; Zelger B
    J Cutan Pathol; 2009 Sep; 36(9):987-90. PubMed ID: 19674202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours.
    Fukunaga M
    Histopathology; 2005 Apr; 46(4):396-402. PubMed ID: 15810951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prox-1 and VEGFR3 antibodies are superior to D2-40 in identifying endothelial cells of lymphatic malformations--a proposal of a new immunohistochemical panel to differentiate lymphatic from other vascular malformations.
    Castro EC; Galambos C
    Pediatr Dev Pathol; 2009; 12(3):187-94. PubMed ID: 18937526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unclassified epithelioid vascular tumor with hemangioendotheliomatous features and lymphatic differentiation.
    Oshiro Y; Kohashi K; Oda Y; Tsuneyoshi M; Shono Y
    Pathol Int; 2009 Jun; 59(6):410-4. PubMed ID: 19490473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of lymphatic endothelium in pediatric vascular tumors and malformations.
    Galambos C; Nodit L
    Pediatr Dev Pathol; 2005; 8(2):181-9. PubMed ID: 15719202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of vascular endothelial growth factor receptor 3 in blood and lymphatic vessels of lung adenocarcinoma.
    Niki T; Iba S; Yamada T; Matsuno Y; Enholm B; Hirohashi S
    J Pathol; 2001 Apr; 193(4):450-7. PubMed ID: 11276003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmoplakin and Plakoglobin--specific markers of lymphatic vessels in the skin?
    Fedele C; Berens D; Rautenfeld V; Pabst R
    Anat Histol Embryol; 2004 Jun; 33(3):168-71. PubMed ID: 15144286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas.
    Kahn HJ; Bailey D; Marks A
    Mod Pathol; 2002 Apr; 15(4):434-40. PubMed ID: 11950918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemangioendothelioma.
    Requena L; Kutzner H
    Semin Diagn Pathol; 2013 Feb; 30(1):29-44. PubMed ID: 23327728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression and distribution of VEGFR-3 in malignant mesothelioma.
    Filho AL; Baltazar F; Bedrossian C; Michael C; Schmitt FC
    Diagn Cytopathol; 2007 Dec; 35(12):786-91. PubMed ID: 18008346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors.
    Lymboussaki A; Partanen TA; Olofsson B; Thomas-Crusells J; Fletcher CD; de Waal RM; Kaipainen A; Alitalo K
    Am J Pathol; 1998 Aug; 153(2):395-403. PubMed ID: 9708800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues.
    Pusztaszeri MP; Seelentag W; Bosman FT
    J Histochem Cytochem; 2006 Apr; 54(4):385-95. PubMed ID: 16234507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma.
    Clarijs R; Schalkwijk L; Hofmann UB; Ruiter DJ; de Waal RM
    Cancer Res; 2002 Dec; 62(23):7059-65. PubMed ID: 12460927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can lymphangiosarcoma be resurrected? A clinicopathological and immunohistochemical study of lymphatic differentiation in 49 angiosarcomas.
    Mankey CC; McHugh JB; Thomas DG; Lucas DR
    Histopathology; 2010 Feb; 56(3):364-71. PubMed ID: 20459536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Composite hemangioendothelioma: report of 5 cases including one with associated Maffucci syndrome.
    Fukunaga M; Suzuki K; Saegusa N; Folpe AL
    Am J Surg Pathol; 2007 Oct; 31(10):1567-72. PubMed ID: 17895759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of D2-40 immunohistochemistry for differentiation between kaposiform hemangioendothelioma and tufted angioma.
    Arai E; Kuramochi A; Tsuchida T; Tsuneyoshi M; Kage M; Fukunaga M; Ito T; Tada T; Izumi M; Shimizu K; Hirose T; Shimizu M
    J Cutan Pathol; 2006 Jul; 33(7):492-7. PubMed ID: 16872472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors.
    Partanen TA; Alitalo K; Miettinen M
    Cancer; 1999 Dec; 86(11):2406-12. PubMed ID: 10590384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues.
    Wilting J; Papoutsi M; Christ B; Nicolaides KH; von Kaisenberg CS; Borges J; Stark GB; Alitalo K; Tomarev SI; Niemeyer C; Rössler J
    FASEB J; 2002 Aug; 16(10):1271-3. PubMed ID: 12060670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.